Aurisco Pharmaceutical Co.,Ltd. (605116.SS)
CNY 20.78
(-0.24%)
CNY 20.78
(-0.24%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 698.31 Million CNY | 35.66% |
| 2022 | 520.39 Million CNY | 31.84% |
| 2021 | 394.71 Million CNY | 15.79% |
| 2020 | 340.9 Million CNY | 14.26% |
| 2019 | 298.36 Million CNY | 10.18% |
| 2018 | 270.78 Million CNY | 2.51% |
| 2017 | 264.14 Million CNY | -13.4% |
| 2016 | 305.02 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 217.03 Million CNY | -5.61% |
| 2024 Q1 | 180.16 Million CNY | -6.5% |
| 2024 Q2 | 228.1 Million CNY | 26.61% |
| 2023 Q4 | 192.68 Million CNY | -19.07% |
| 2023 FY | 705.97 Million CNY | 35.66% |
| 2023 Q3 | 238.1 Million CNY | 73.13% |
| 2023 Q2 | 137.52 Million CNY | -0.09% |
| 2023 Q1 | 137.65 Million CNY | -0.03% |
| 2022 Q3 | 120.77 Million CNY | -13.81% |
| 2022 FY | 520.39 Million CNY | 31.84% |
| 2022 Q2 | 140.12 Million CNY | 15.05% |
| 2022 Q1 | 121.79 Million CNY | 15.43% |
| 2022 Q4 | 137.69 Million CNY | 14.01% |
| 2021 Q2 | 105.68 Million CNY | 32.58% |
| 2021 Q1 | 79.71 Million CNY | 21.88% |
| 2021 Q4 | 105.51 Million CNY | 1.65% |
| 2021 Q3 | 103.8 Million CNY | -1.78% |
| 2021 FY | 394.71 Million CNY | 15.79% |
| 2020 Q1 | 90.88 Million CNY | 10.35% |
| 2020 FY | 340.9 Million CNY | 14.26% |
| 2020 Q4 | 65.4 Million CNY | -22.33% |
| 2020 Q3 | 84.2 Million CNY | -16.14% |
| 2020 Q2 | 100.4 Million CNY | 10.48% |
| 2019 Q4 | 82.35 Million CNY | 5.95% |
| 2019 Q3 | 77.73 Million CNY | 0.0% |
| 2019 FY | 298.36 Million CNY | 10.18% |
| 2018 FY | 270.78 Million CNY | 2.51% |
| 2017 FY | 264.14 Million CNY | -13.4% |
| 2016 FY | 305.02 Million CNY | 0.0% |